Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Jandlová

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Folia Biologica|January 1, 1992
Chemoimmunotherapy of cancer: cyclophosphamide-resistant tumour cells are equally sensitive as the original tumour cell population to local IL-2 immunotherapyJ Símová, J Bubeník, T Jandlová
Immunology Letters|February 1, 1990
Immunotherapy of cancer using local administration of lymphoid cells transformed by IL-2 cDNA and constitutively producing IL-2J Bubeník, J Símová, T Jandlová
Folia Biologica|January 1, 1992
Interaction of interleukin 2 and interleukin 4 during LAK cell generationM Indrová, T Jandlová, J Bubeník
Anticancer Research|September 1, 1992
Age-related decrease in transplantability of human tumours in nu/nu miceJ Bubeník, J Kieler, T Jandlová, et al.
Folia Biologica|December 19, 2003
Immunotherapy of HPV 16-associated tumours with tumour cell line/dendritic cell line (TC-1/DC2.4) hybrid vaccinesJ Símová, J Bieblová, T Jandlová, et al.
Neoplasma|January 1, 1981
Electrophoretic mobility profiles of mouse leukemias: I. Electrophoresis of normal mouse thymus and lymph node cell populationsJ Bubeník, D Bubeníková, J Lastovicka, et al.
Folia Biologica|February 16, 2005
The role of NK1.1+ cells in the protection against MHC class I+ HPV16-associated tumoursJ Símová, J Bubeník, J Bieblová, et al.
International Journal of Oncology|June 6, 1998
Irradiated IL-2 gene-modified plasmacytoma vaccines are more efficient than live vaccinesJ Símová, J Bubeník, T Jandlová, et al.
Neoplasma|January 1, 1979
Cell surface adhesiveness of mouse sarcoma lines evaluated by latex particle adherence assay: correlation with growth behavior and electrophoretic mobilityJ Bubeník, T Jandlová, E Suhajová, et al.
Folia Biologica|October 31, 2000
Intratumoral IL-12 gene transfer improves the therapeutic efficacy of IL-12 but not IL-19V Sobota, J Bubeník, J Símová, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Folia Biologica|January 1, 1992
Chemoimmunotherapy of cancer: cyclophosphamide-resistant tumour cells are equally sensitive as the original tumour cell population to local IL-2 immunotherapyJ Símová, J Bubeník, T Jandlová
Immunology Letters|February 1, 1990
Immunotherapy of cancer using local administration of lymphoid cells transformed by IL-2 cDNA and constitutively producing IL-2J Bubeník, J Símová, T Jandlová
Folia Biologica|January 1, 1992
Interaction of interleukin 2 and interleukin 4 during LAK cell generationM Indrová, T Jandlová, J Bubeník
Anticancer Research|September 1, 1992
Age-related decrease in transplantability of human tumours in nu/nu miceJ Bubeník, J Kieler, T Jandlová, et al.
Folia Biologica|December 19, 2003
Immunotherapy of HPV 16-associated tumours with tumour cell line/dendritic cell line (TC-1/DC2.4) hybrid vaccinesJ Símová, J Bieblová, T Jandlová, et al.
Neoplasma|January 1, 1981
Electrophoretic mobility profiles of mouse leukemias: I. Electrophoresis of normal mouse thymus and lymph node cell populationsJ Bubeník, D Bubeníková, J Lastovicka, et al.
Folia Biologica|February 16, 2005
The role of NK1.1+ cells in the protection against MHC class I+ HPV16-associated tumoursJ Símová, J Bubeník, J Bieblová, et al.
International Journal of Oncology|June 6, 1998
Irradiated IL-2 gene-modified plasmacytoma vaccines are more efficient than live vaccinesJ Símová, J Bubeník, T Jandlová, et al.
Neoplasma|January 1, 1979
Cell surface adhesiveness of mouse sarcoma lines evaluated by latex particle adherence assay: correlation with growth behavior and electrophoretic mobilityJ Bubeník, T Jandlová, E Suhajová, et al.
Folia Biologica|October 31, 2000
Intratumoral IL-12 gene transfer improves the therapeutic efficacy of IL-12 but not IL-19V Sobota, J Bubeník, J Símová, et al.
Pageof 5